More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline... (or should discuss the need for adequate ...)

HOME >> MEDICINE >> TECHNOLOGY

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

Date:12/3/2008

or should discuss the need for adequate birth control if you have the potential to become pregnant, if you are not sure of your postmenopausal status, or if you recently became postmenopausal. Femara is only indicated in postmenopausal women. Talk to your doctor if you're allergic to Femara or any of its ingredients. You should not take Femara if you are pregnant, as it may cause fetal harm. Some women reported fatigue and dizziness with Femara. Until you know how it affects you, use caution before driving or operating machinery. Some patients taking Femara had an increase in cholesterol. Additional follow-up is needed to determine the risk of bone fracture associated with long-term use of Femara.

In the adjuvant setting, commonly reported side effects are generally mild to moderate. The most common side effects seen with Femara include hot flashes, joint pain, night sweats, weight gain, nausea, tiredness, other heart-related events and bone fractures. Other less commonly reported side effects include vaginal bleeding, blood clots, other cancers, osteoporosis, stroke, heart attack and endometrial cancer.

In the extended adjuvant setting, commonly reported side effects are generally mild to moderate. Commonly reported side effects for Femara include hot flashes, fatigue, joint pain, headache, increase in sweating, swelling due to fluid retention, increase in cholesterol, dizziness, constipation, nausea, cardiovascular ischemic events, muscle pain, osteoporosis, arthritis and bone fracture.

In the metastatic cancer setting, commonly reported side effects are generally mild to moderate and may include bone pain, hot flashes, back pain, nausea, joint pain, shortness of breath, tiredness, coughing, constipation, limb pain, chest pain and headache.

About Zometa

Zometa(R) (zoledronic acid) is indicated for patients with multiple myeloma and documented bone metastases from
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat

Post Your Comments:

(Date:12/16/2009)... 16 Siemens Healthcare today ... to help healthcare ... deadlines defined within the HITECH provision of ... Featuring zero-percent interest terms for ... defer up-front payments associated with their technology ...

(Date:12/16/2009)... -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... products, today announced top-line efficacy and safety results ... for the treatment of Peyronie,s disease. Peyronie,s disease ... on the shaft of the penis, which can ... or impossible in advanced cases. The Phase 2b ...

(Date:12/16/2009)... MAQUET Cardiovascular LLC, a leading ... it has signed a three-year single source ... supply contracting company, for MAQUET,s market-leading VASOVIEW ... products assist healthcare providers in obtaining veins ... only small incisions. This allows for faster ...

Breaking Medicine Technology:Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2 Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3 Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3 BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3 MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4 New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 1 New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 2 Aon Declares Quarterly Dividend 59320 1 Aon Declares Quarterly Dividend 59320 2 Hogs n Hens for Hope NCPC BBQ Cook Off 26amp 3B Festival October 17 at Duplin County Events Center Features Fun for the Whole Family and Benefits Laz 59317 1 Hogs n Hens for Hope NCPC BBQ Cook Off 26amp 3B Festival October 17 at Duplin County Events Center Features Fun for the Whole Family and Benefits Laz 59317 2

[0] Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use [0] BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease [0] MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices

... Assess Safety and Dose-Sparing Capability of Iomai Adjuvant ... ... Corporation,(Nasdaq: IOMI ) today announced that it has begun dosing in ... the,company,s immunostimulant patch when used in combination with an injected,H5N1 influenza vaccine. ...

... ANN ARBOR, Mich., Sept. 6 Terumo Heart ... Launch Symposium at the European,Association of Cardio-Thoracic Surgeons ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ... ) A summary of the European ...

Other Medicine Technology:Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 2 Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 3 Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine 4 Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September 2

Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September

(Date:12/16/2009)... Dec. 16 HealthSciences Institute will ... care professionals, teams and organizations who serve ... chronic diseases in employer, health plan, medical ... collaborative will offer free, noncommercial webinars on ... disease prevention, management and care improvement. Each ...

(Date:12/16/2009)... Trust Sanger Institute announce the first comprehensive analyses of ... mutations in the DNA of cancer cells which are ... malignant melanoma and a lung cancer, reveal for the ... of two cancers. , Lung cancer causes around one ... with smoking. The number of mutations found suggest that ...

(Date:12/16/2009)... Newborn-Safe Skin Care Products from Episencial Offers Planet-Friendly Organics, Solar-Powered ... , ... Los Angeles, CA (PRWEB) ... now have an authentic, affordable choice in all natural skin ... its eponymous product line for young children featuring the beloved ...

(Date:12/16/2009)... leader of Digital Pen and Paper technology and the provider ... today announced that it is ranked among the Fastest Growing ... 2009. , ... (PRWEB) December 16, ... for the capture, digitalization and management of handwritten data. Kayentis ...

(Date:12/16/2009)... 8 percent of children are uninsured, government report finds ... first six months of this year, 45.4 million Americans ... population -- had no health insurance, according to new ... addition, 58.4 million (19.4 percent) people of all ages ... year prior to the interview, and 31.9 million (10.6 ...

Breaking Medicine News(10 mins):Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2 Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3 Health News:Lung cancer and melanoma laid bare 2 Health News:Lung cancer and melanoma laid bare 3 Health News:Lung cancer and melanoma laid bare 4 Health News:Lung cancer and melanoma laid bare 5 Health News:Lung cancer and melanoma laid bare 6 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4 Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5 Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2 Health News:Over 45 Million Americans Now Lack Health Insurance 2

[1] New Learning Collaborative to Prepare Clinicians for Better Chronic Care [1] Lung cancer and melanoma laid bare [1] New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" [0] With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 [1] Over 45 Million Americans Now Lack Health Insurance

... The Cystic Fibrosis Foundation reported today that key indicators ... lung function and nutritional status -- are rising nationwide ... the outlook for people with CF continues to improve ... due to quality improvement programs spearheaded by the CF ...

... 28 The newest product offered by,Terumo ... Terumo Interventional Systems announces the launch ... the occlusion of blood,vessels, vascular malformations, and ... embolization system with a hydrogel coating that ...

... 28 The following letter is,being released by CEL-SCI ... Dear Fellow Shareholders:, Our Company underwent a wonderful ... development to a late-stage biotechnology,company. We are now one ... a,completely novel medicine with blockbuster potential ready to go ...

... is the latest American Chemical Society (ACS) News Service Weekly ... & Engineering News.,Please credit the individual journal or the American ... CONTENT IS FOR IMMEDIATE USE EXCEPT ARTICLE #5, which is ... , ARTICLE #1 FOR IMMEDIATE RELEASE ...

... Research Institute (CRI) announced today that it has brought ... Sabin Vaccine Institute, and the Cancer Vaccine Collaborative, a ... Ludwig Institute for Cancer Research (LICR), to form the ... a unified voice in the cancer vaccine field and ...

... 4:30 p.m. Eastern Time -, SAN FRANCISCO, Jan. ... that, based on its end-of-Phase 2 meeting,with the U.S. ... a pivotal confirmatory Phase 3 trial of Dimebon(TM) for,mild-to-moderate ... The FDA informed Medivation that the company,s previously completed,trial ...

Cystic Fibrosis Foundation reports upward trend for key health outcomes Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology CEL-SCI Corporation Releases Letter to Shareholders American Chemical Society's weekly PressPac -- Jan. 23, 2008 Cancer Vaccine Consortium and Cancer Vaccine Collaborative unite under the Cancer Research Institute Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008

... Ophthalmoscope with superior aspherical optics. The separation ... of the aspherical optical system avoids corneal ... allows you to view the whole of ... with a small pupil. Conventional ophthalmoscopes often ...

... Heine Beta 200S is the ... a combination of patented aspherical ... a range of corrective lenses ... in single diopter steps. A ...

With the unique automatic focus system, Autofoc 2 remains the instrument of choice for direct ophthalmoscopy. Includes XHL halogen bulb....

... optics. The separation of illumination and observation ... system avoids corneal and iris reflex (Gullstrand-principle). ... the whole of the illuminated section of ... Conventional ophthalmoscopes often let you see only ...

Medicine Products:

3.5V Beta 200 M2 2.5V Heine Beta 200S 2.5V Autofoc 2 Ophthalmoscope 2.5V Ophthalmic BETA 200 Pro

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline...(or should discuss the need for adequate ...),Health